China announced Thursday that it has granted conditional marketing authorization for its first domestically-developed COVID-19 vaccine. The inactivated vaccine was developed by the Beijing Institute of Biological Products Co., Ltd. According to National Medical Products Administration, the vaccine has a 79.34 percent efficacy against COVID-19, meeting the World Health Organization (WHO) and the State Food and Drug Administration standards. The COVID-19 vaccine will be offered free to citizens.





For more:
https://www.cgtn.com/video

Subscribe to us on YouTube: https://goo.gl/lP12gA
Download our APP on Apple Store (iOS): https://itunes.apple.com/us/app/cctvnews-app/id922456579?l=zh&ls=1&mt=8
Download our APP on Google Play (Android): https://play.google.com/store/apps/details?id=com.imib.cctv